| Item Type | Name |
|
Concept
|
Diuretics
|
|
Academic Article
|
Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy.
|
|
Academic Article
|
Antihypertensive therapy and the risk of type 2 diabetes mellitus.
|
|
Academic Article
|
A practical approach to achieving recommended blood pressure goals in diabetic patients.
|
|
Academic Article
|
Optimal treatment of hypertension in African Americans. Reaching and maintaining target blood pressure goals.
|
|
Academic Article
|
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.
|
|
Academic Article
|
Achieving blood pressure goals: is fixed-dose combination therapy the answer?
|
|
Academic Article
|
Diabetes and chronic kidney disease: tragedy and challenge.
|
|
Academic Article
|
When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk.
|
|
Academic Article
|
Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction.
|
|
Academic Article
|
Management of hypertension in the cardiometabolic syndrome and diabetes.
|
|
Academic Article
|
Cardiology patient page. Kidney failure and cardiovascular disease.
|
|
Academic Article
|
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
|
|
Academic Article
|
Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
|
|
Academic Article
|
Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.
|
|
Academic Article
|
Blood pressure control in the patient with difficult-to-control hypertension: which agent for which patient?
|
|
Academic Article
|
Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
|
|
Academic Article
|
Who should be treated with combination therapy as initial treatment for hypertension?
|
|
Academic Article
|
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
|
|
Academic Article
|
Newer combination therapies in the management of hypertension: an update.
|
|
Academic Article
|
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
|
|
Academic Article
|
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.
|
|
Academic Article
|
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
|
|
Academic Article
|
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.
|
|
Academic Article
|
Resistant hypertension: an overview of evaluation and treatment.
|
|
Academic Article
|
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
|
|
Academic Article
|
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
|
|
Academic Article
|
Treatment and control of high blood pressure in adults.
|
|
Academic Article
|
The evolution of antihypertensive therapy: an overview of four decades of experience.
|
|
Academic Article
|
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
|
|
Academic Article
|
Mechanistic insights into diuretic-induced insulin resistance.
|
|
Academic Article
|
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
|
|
Academic Article
|
Renal effects of antihypertensive medications: an overview.
|
|
Academic Article
|
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
|
|
Academic Article
|
Renal adaptation to the failing heart. Avoiding a 'therapeutic misadventure'.
|
|
Academic Article
|
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
|
|
Academic Article
|
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
|
|
Academic Article
|
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
|
|
Academic Article
|
Combination therapy in hypertension.
|
|
Academic Article
|
Fixed-dose combination and chronic kidney disease progression: which is the best?
|
|
Academic Article
|
Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
|
|
Academic Article
|
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
|
|
Academic Article
|
Treatment of renal failure and blood pressure.
|
|
Academic Article
|
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
|
|
Academic Article
|
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review.
|
|
Academic Article
|
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
|
|
Academic Article
|
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.
|
|
Academic Article
|
The double challenge of resistant hypertension and chronic kidney disease.
|
|
Academic Article
|
Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit.
|
|
Academic Article
|
Baseline characteristics and enrichment results from the SONAR trial.
|
|
Academic Article
|
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
|
|
Academic Article
|
Hypertension.
|
|
Academic Article
|
Redefining diuretics use in hypertension: why select a thiazide-like diuretic?
|
|
Academic Article
|
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
|
|
Academic Article
|
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
|